Abstract:Despite 3D bioprinting having emerged as an advanced method for fabricating complex in vitro models, developing suitable bioinks that fulfill the opposing requirements for the biofabrication window still remains challenging. Although naturally derived hydrogels can better mimic the extracellular matrix (ECM) of numerous tissues, their weak mechanical properties usually result in architecturally simple shapes and patchy functions of in vitro models. Here, this limitation is addressed by a peptide-dendrimer-reinforced bioink (HC-PDN) which contained the peptide-dendrimer branched PEG with end-grafted norbornene (PDN) and the cysteamine-modified HA (HC). The extensive introduction of ethylene end-groups facilitates the grafting of sufficient moieties and enhances thiol-ene-induced crosslinking, making HC-PDN exhibits improved mechanical and rheological properties, as well as a significant reduction in reactive oxygen species (ROS) accumulation than that of methacrylated hyaluronic acid (HAMA). In addition, HC-PDN can be applied for the bioprinting of numerous complex structures with superior shape fidelity and soft matrix microenvironment. A heterogeneous and biomimetic hepatic tissue is concretely constructed in this work. The HepG2-C3As, LX-2s, and EA.hy.926s utilized with HC-PDN and assisted GelMA bioinks closely resemble the parenchymal and non-parenchymal counterparts of the native liver. The bioprinted models show the endothelium barrier function, hepatic functions, as well as increased activity of drug-metabolizing enzymes, which are essential functions of liver tissue in vivo . All these properties make HC-PDN a promising bioink to open numerous opportunities for in vitro model biofabrication. Statement of significance In this manuscript, we introduced a peptide dendrimer system, which belongs to the family of hyperbranched 3D nanosized macromolecules that exhibit high molecular structure regularity and various biological advantages. Specifically, norbornene-modified peptide dendrimer was grafted onto PEG, and hyaluronic acid (HA) was selected as a base material for bioink formulation because it is a component of the ECM. Peptide dendrimers confer the following advantages to bioinks: a) Geometric symmetry can facilitate construction of bioinks with homogeneous networks; b) abundant surface functional groups allow for abundant crosslinking points; c) the biological origin can promote biocompatibility. This study shows conceptualization to application of a peptide-dendrimer bioink to extend the Biofabrication Window of natural bioinks and will expand use of 3D bioprinting of in vitro models.

Bioink Derived from Human Placenta Supporting Angiogenesis.

Thermo-sensitive Sacrificial Microsphere-based Bioink for Centimeter-scale Tissue with Angiogenesis

Harnessing Human Placental Membrane-Derived Bioinks: Characterization and Applications in Bioprinting and Vasculogenesis

3D Printing of Vascularized Hepatic Tissues with a High Cell Density and Heterogeneous Microenvironment.

A heparin-functionalized bioink with sustained delivery of vascular endothelial growth factor for 3D bioprinting of prevascularized dermal constructs

Directly Coaxial 3D Bioprinting of Large-Scale Vascularized Tissue Constructs.

Sacrificial Microgel-Laden Bioink-Enabled 3D Bioprinting of Mesoscale Pore Networks

3D Printing of Cell‐Laden Microgel‐Based Biphasic Bioink with Heterogeneous Microenvironment for Biomedical Applications

Extracellular‐Matrix‐Reinforced Bioinks for 3D Bioprinting Human Tissue

Modeling the Printability of Photocuring and Strength Adjustable Hydrogel Bioink During Projection-Based 3D Bioprinting.

Peptide-Dendrimer-Reinforced Bioinks for 3D Bioprinting of Heterogeneous and Biomimetic in vitro Models

3D bioprinting microgels to construct implantable vascular tissue

Inkjet 3D Bioprinting for Tissue Engineering and Pharmaceutics

Three-Dimensional Bioprinting of Decellularized Extracellular Matrix-Based Bioinks for Tissue Engineering

Fabrication and characterization of a pro-angiogenic hydrogel derived from the human placenta

Recent Advancements of Bioinks for 3D Bioprinting of Human Tissues and Organs.

Bioinks for bioprinting using plant-derived biomaterials

Microfiber-Templated Porogel Bioinks Enable Tubular Interfaces and Microvascularization Down to the Building Blocks for 3D Bioprinting

Expanding Embedded 3D Bioprinting Capability for Engineering Complex Organs with Freeform Vascular Networks

In Situ Endothelialization of Free-Form 3D Network of Interconnected Tubular Channels via Interfacial Coacervation by Aqueous-in-Aqueous Embedded Bioprinting

Direct 3D bioprinting of perfusable vascular constructs using a blend bioink